[1]邹 璐,姚黎清.心血管药物基因多态性与脑卒中相关性研究进展[J].医学信息,2022,35(07):15-18.[doi:10.3969/j.issn.1006-1959.2022.07.004]
 ZOU Lu,YAO Li-qing.Research Progress on the Correlation Between Cardiovascular Drug Gene Polymorphism and Stroke[J].Medical Information,2022,35(07):15-18.[doi:10.3969/j.issn.1006-1959.2022.07.004]
点击复制

心血管药物基因多态性与脑卒中相关性研究进展()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年07期
页码:
15-18
栏目:
综述
出版日期:
2022-04-01

文章信息/Info

Title:
Research Progress on the Correlation Between Cardiovascular Drug Gene Polymorphism and Stroke
文章编号:
1006-1959(2022)07-0015-04
作者:
邹 璐姚黎清
(昆明医科大学第二附属医院康复医学部,云南 昆明 650000)
Author(s):
ZOU LuYAO Li-qing
(Department of Rehabilitation Medicine,the Second Affiliated Hospital of Kunming Medical University,Kunming 650000,Yunnan,China)
关键词:
脑卒中药物基因组学心血管病药物个性化用药
Keywords:
StrokePharmacogeneticsCardiovascular drugsPersonalized drug use
分类号:
R743.3
DOI:
10.3969/j.issn.1006-1959.2022.07.004
文献标志码:
A
摘要:
个体对药物吸收、转运、代谢、消除的不同是基于药物基因组学的多态性。在心血管相关药物基因组学中,有研究表明,其不仅影响药物的有效性、安全性,部分基因还与脑卒中进展、预后相关。本文对目前常见的心血管药物基因对脑卒中患者的进展、预后作一综述,为临床用药指导及判断患者预后提供部分思路。
Abstract:
Individual differences in drug absorption, transportation, metabolism and elimination are based on polymorphism of pharmacogenomics. In the genomics of cardiovascular related drugs, some studies have shown that they not only affect the effectiveness and safety of drugs, some genes are related to the progress and prognosis of stroke. This article reviews the progress and prognosis of common cardiovascular drug genes in stroke patients, and provides some ideas for clinical medication guidance and prognosis judgment.

参考文献/References:

[1]王丹,任经天,董铎,等.药品不良反应监测年度报告十年趋势分析[J].中国药物警戒,2020,17(5):276-283.[2]农秋萍,廖小平,李其富,等.缺血性脑卒中的遗传风险因素[J].海南医学,2018,29(17):2452-2458.[3]Wei LK,Au A,Menon S,et al.Polymorphisms of MTHFR, eNOS, ACE, AGT, ApoE, PON1, PDE4D, and Ischemic Stroke: Meta-Analysis[J].J Stroke Cerebrovasc Dis,2017,26(11):2482-2493.[4]Phillips MC.Apolipoprotein E isoforms and lipoprotein metabolism[J].IUBMB Life,2014,66(9):616-623.[5]Konialis C,Spengos K,Iliopoulos P,et al.The APOE E4 Allele Confers Increased Risk of Ischemic Stroke Among Greek Carriers[J].Adv Clin Exp Med,2016,25(3):471-478.[6]Pendlebury ST,Poole D,Burgess A,et al.APOE-ε4 Genotype and Dementia Before and After Transient Ischemic Attack and Stroke:Population-Based Cohort Study[J].Stroke,2020,51(3):751-758.[7]Chen C,Hu Z.ApoE Polymorphisms and the Risk of Different Subtypes of Stroke in the Chinese Population: A Comprehensive Meta-Analysis[J].Cerebrovasc Dis,2016,41(3-4):119-138.[8]Zhang L,Lv H,Zhang Q,et al.Association of SLCO1B1 and ABCB1 Genetic Variants with Atorvastatin-induced Myopathy in Patients with Acute Ischemic Stroke[J].Curr Pharm Des,2019,25(14):1663-1670.[9]Stránecky V,Neroldová M,Hodaňová K,et al.Large copy-number variations in patients with statin-associated myopathy affecting statin myopathy-related loci[J].Physiol Res,2016,65(6):1005-1011.[10]罗宝昌,张敬.ApoE和Slco1B1基因多态性与缺血性脑卒中的相关性分析[J].卒中与神经疾病,2018,25(3):264-266,271.[11]Sienkiewicz-Oleszkiewicz B,Wiela-Hojeńska A.CYP2C19 polymorphism in relation to the pharmacotherapy optimization of commonly used drugs[J].Pharmazie,2018,73(11):619-624.[12]Wang Y,Zhao X,Lin J,et al.Association Between CYP2C19 Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack[J].JAMA,2016,316(1):70-78.[13]白云雪.缺血性卒中患者CYP2C19基因多态性与血脂水平的关系[D].南昌:南昌大学,2020.[14]Tabas I.2016 Russell Ross Memorial Lecture in Vascular Biology: Molecular-Cellular Mechanisms in the Progression of Atherosclerosis[J].Arterioscler Thromb Vasc Biol,2017,37(2):183-189.[15]Krishnan R,Sekar D,Karunanithy S,et al.Association of angiotensin converting enzyme gene insertion/deletion polymorphism with essential hypertension in south Indian population[J].Genes Dis,2016,3(2):159-163.[16]Imbalzano E,Vatrano M,Quartuccio S,et al.Clinical impact of angiotensin I converting enzyme polymorphisms in subjects with resistant hypertension[J].Mol Cell Biochem,2017,430(1-2):91-98.[17]de Denus S,Zakrzewski-Jakubiak M,Dubé MP,et al.Effects of AGTR1 A1166C gene polymorphism in patients with heart failure treated with candesartan[J].Ann Pharmacother,2008,42(7):925-932.[18]Procopciuc LM,Sitar-Taut A,Pop D,et al.Renin angiotensin system polymorphisms in patients with metabolic syndrome (MetS) [J].Eur J Intern Med,2010,21(5):414-418.[19]Malueka RG,Dwianingsih EK,Sutarni S,et al.The D allele of the angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism is associated with worse functional outcome of ischaemic stroke[J].International Journal of Neuroscience,2018,128(8):1-21.[20]Pacholczyk M,Ferenc T,Kowalski J,et al.Association of angiotensin-converting enzyme and angiotensin Ⅱ type Ⅰ receptor gene polymorphisms with extreme obesity in Polish individuals[J].DNA Cell Biol,2013,32(8):435-442.[21]Li A,Shi Y,Xu L,et al.A possible synergistic effect of MTHFR C677T polymorphism on homocysteine level variations increased risk for ischemic stroke[J].Medicine (Baltimore),2017,96(51):e9300.[22]周丽萍,乔羲,刘毓刚,等.血清同型半胱氨酸及其代谢相关基因MTHFR多态性与缺血性脑卒中发生及预后的关系[J].标记免疫分析与临床,2017,24(3):241-246.[23]Zhang W,Sun K,Chen J,et al.High plasma homocysteine levels contribute to the risk of stroke recurrence and all-cause mortality in a large prospective stroke population[J].Clinical Science,2009,118(3):187.[24]Zhang R,Wang J,Xue M,et al.ALDH2---The Genetic Polymorphism and Enzymatic Activity Regulation: Their Epidemiologic and Clinical Implications[J].Curr Drug Targets,2017,18(15):1810-1816.[25]Chen CH,Ferreira JCB,Mochly-Rosen D.ALDH2 and Cardiovascular Disease[J].Adv Exp Med Biol,2019(1193):53-67.[26]Xu H,Zhang Y,Ren J.ALDH2 and Stroke:A Systematic Review of the Evidence[J].Adv Exp Med Biol,2019(1193):195-210.[27]Xu T,Liu S,Ma T,et al.Aldehyde dehydrogenase 2 protects against oxidative stress associated with pulmonary arterial hypertension[J].Redox Biol,2017(11):286-296.[28]Yang H,Song Z,Yang GP,et al.The ALDH2 rs671 polymorphism affects post-stroke epilepsy susceptibility and plasma 4-HNE levels[J].PLoS One,2014,9(10):e109634.[29]刘卫,张许,吴传亮,等.缺血性卒中二级预防后复发的危险因素及药物干预对4-HNE浓度的影响[J].中国药房,2021,32(8):991-995.[30]Tao Y,Chen YJ,Fu X,et al.Evolutionary Ensemble Learning Algorithm to Modeling of Warfarin Dose Prediction for Chinese[J].IEEE J Biomed Health Inform,2019,23(1):395-406.[31]Johnson JA,Caudle KE,Gong L,et al.Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update[J].Clin Pharmacol Ther,2017,102(3):397-404.[32]Rüdesheim S,Wojtyniak JG,Selzer D,et al.Physiologically Based Pharmacokinetic Modeling of Metoprolol Enantiomers and α-Hydroxymetoprolol to Describe CYP2D6 Drug-Gene Interactions[J].Pharmaceutics,2020,12(12):1200.[33]Guerra LA,Lteif C,Arwood MJ,et al.Genetic polymorphisms in ADRB2 and ADRB1 are associated with differential survival in heart failure patients taking β-blockers[J].Pharmacogenomics J,Epub 2021 Oct 12.[34]李艳翠,方芳,方舟,等.CYP2D6*10、ADRB1基因多态性在高血压患者中的分布[J].黑龙江医药科学,2019,42(4):9-12.

相似文献/References:

[1]尹美丽.早期康复护理对脑卒中临床疗效及偏瘫肢体功能的影响分析[J].医学信息,2018,31(05):167.[doi:10.3969/j.issn.1006-1959.2018.05.061]
 YIN Mei-li.Effect of Early Rehabilitation Nursing on Clinical Effect of Stroke and Limb Function of Hemiplegia[J].Medical Information,2018,31(07):167.[doi:10.3969/j.issn.1006-1959.2018.05.061]
[2]杨立丹,吴 敬,王学军.调神益髓针刺法结合康复训练治疗脑卒中后 平衡功能障碍的临床分析[J].医学信息,2018,31(07):143.[doi:10.3969/j.issn.1006-1959.2018.07.049]
 YANG Li-dan,WU Jing,WANG Xue-jun.Clinical Analysis of Treatment of Balance Dysfunction after Stroke by Acupuncture of Regulating Spirit and Supplementing Pulp Combined with Rehabilitation Training[J].Medical Information,2018,31(07):143.[doi:10.3969/j.issn.1006-1959.2018.07.049]
[3]王晓强,张艳军,贾 琎,等.早期康复介入与脑卒中合并代谢综合征患者并发症的关系[J].医学信息,2018,31(08):96.[doi:10.3969/j.issn.1006-1959.2018.08.030]
 WANG Xiao-qiang,ZHANG Yan-jun,JIA Jin,et al.Relationship between Early Rehabilitation Intervention and Complications in Stroke Patients with Metabolic Syndrome[J].Medical Information,2018,31(07):96.[doi:10.3969/j.issn.1006-1959.2018.08.030]
[4]侯艳雁,王 杰,邓丛磊.重复经颅磁刺激联合步态适应性训练对脑卒中患者运动康复及生活质量的影响[J].医学信息,2022,35(09):157.[doi:10.3969/j.issn.1006-1959.2022.09.040]
 HOU Yan-yan,WANG Jie,DENG Cong-lei.Effects of Repetitive Transcranial Magnetic Stimulation Combined with Gait Adaptive Training on Motor Rehabilitation and Quality of Life in Patients with Stroke[J].Medical Information,2022,35(07):157.[doi:10.3969/j.issn.1006-1959.2022.09.040]
[5]李娅娜,曹 岚,徐 影,等.四肢联动联合虚拟现实训练对脑卒中恢复期患者 下肢功能与平衡功能的影响[J].医学信息,2018,31(14):107.[doi:10.3969/j.issn.1006-1959.2018.14.031]
 LI Ya-na,CAO Lan,XU Ying,et al.Effects of Limb Linkage and Virtual Reality Training on Lower Limb Function and Balance Function in Stroke Patients during Convalescence[J].Medical Information,2018,31(07):107.[doi:10.3969/j.issn.1006-1959.2018.14.031]
[6]邵俊丽.静息心率与脑卒中关系的研究[J].医学信息,2018,31(16):16.[doi:10.3969/j.issn.1006-1959.2018.16.006]
 SHAO Jun-li.Research on Relationship between Resting Heart Rate and Stroke[J].Medical Information,2018,31(07):16.[doi:10.3969/j.issn.1006-1959.2018.16.006]
[7]张怀祥,段晓宇.脑梗死后认知障碍的病理学机制、相关危险因素及治疗[J].医学信息,2018,31(16):21.[doi:10.3969/j.issn.1006-1959.2018.16.007]
 ZHANG Huai-xiang,DUAN Xiao-yu.Pathological Mechanism,Related Risk Factors and Treatment of Cognitive Impairment after Cerebral Infarction[J].Medical Information,2018,31(07):21.[doi:10.3969/j.issn.1006-1959.2018.16.007]
[8]平兴团,赵富强,杨 飞,等.家庭康复管理对卒中患者运动功能恢复的远期影响[J].医学信息,2018,31(16):66.[doi:10.3969/j.issn.1006-1959.2018.16.018]
 PING Xing-tuan,ZHAO Fu-qiang,YANG Fei,et al.Long-term Effects of Family Rehabilitation Management on Recovery of Motor Function in Stroke Patients[J].Medical Information,2018,31(07):66.[doi:10.3969/j.issn.1006-1959.2018.16.018]
[9]刘 萍,傅继红.30°斜坡式自动充气枕在鼻饲脑卒中 患者体位管理的可行性研究[J].医学信息,2018,31(17):170.[doi:10.3969/j.issn.1006-1959.2018.17.054]
 LIU Ping,FU Ji-hong.Feasibility Study on the Position Management of 30°Slope Automatic Inflatable Pillow in Patients with Nasal Feeding Stroke[J].Medical Information,2018,31(07):170.[doi:10.3969/j.issn.1006-1959.2018.17.054]
[10]赵富强,平兴团,杨 飞,等.重心重塑训练对Pusher综合征的疗效观察[J].医学信息,2018,31(20):94.[doi:10.3969/j.issn.1006-1959.2018.20.027]
 ZHAO Fu-qiang,PING Xing-tuan,YANG Fei,et al.Therapeutic Effect of Center of Gravity Remodeling Training on Pusher Syndrome[J].Medical Information,2018,31(07):94.[doi:10.3969/j.issn.1006-1959.2018.20.027]

更新日期/Last Update: 1900-01-01